Biotoxtech Co. Ltd (086040) — Cash Flow Quality Index
Biotoxtech Co. Ltd (086040) has a Cash Flow Quality Index of -0.06x as of September 2025. Operating cash flow of ₩-354.72 Million is below net income of ₩5.51 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore cash efficiency ratio of Biotoxtech Co. Ltd to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Biotoxtech Co. Ltd Cash Flow Quality Index (2011–2022)
Historical Cash Flow Quality Index for Biotoxtech Co. Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 086040 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Biotoxtech Co. Ltd (2011–2022)
Year-by-year earnings quality comparison for Biotoxtech Co. Ltd. For live market cap and the full company financial profile, see Biotoxtech Co. Ltd stock valuation.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -0.48x | ₩-1.31 Billion | ₩2.73 Billion | ▼ -178.6% |
| 2021 | 0.61x | ₩4.35 Billion | ₩7.11 Billion | ▼ -65.0% |
| 2020 | 1.75x | ₩4.56 Billion | ₩2.61 Billion | ▲ +106.7% |
| 2018 | 0.84x | ₩3.06 Billion | ₩3.62 Billion | ▼ -80.5% |
| 2017 | 4.33x | ₩6.02 Billion | ₩1.39 Billion | ▼ -5.0% |
| 2016 | 4.55x | ₩5.28 Billion | ₩1.16 Billion | ▲ +277.2% |
| 2012 | 1.21x | ₩1.63 Billion | ₩1.35 Billion | ▲ +20.4% |
| 2011 | 1.00x | ₩3.28 Billion | ₩3.27 Billion | — |